0
0
New Delhi, June 9 — Mood disorders such as depression, bipolar disorder, or mania emerging after the age of 40 may be more than just mental health issues—they could serve as early indicators of neurodegenerative diseases like dementia, according to a groundbreaking study released on Monday. Researchers from the National Institutes for Quantum Science and Technology (QST) in Japan have uncovered a strong link between these late-life mood disorders (LLMDs) and the accumulation of abnormal proteins in the brain, which are hallmarks of neurodegenerative conditions.
The study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, involved advanced brain imaging of 52 participants with LLMDs and 47 healthy controls. Using positron emission tomography (PET) scans with specialized tracers, the team detected various forms of tau protein and amyloid beta deposits—key indicators of Alzheimer’s and other neurodegenerative diseases. Additionally, the researchers analyzed brain tissue samples from 208 autopsy cases to further investigate the relationship between late-life mood symptoms and neurodegenerative changes.
Key Findings
-
Tau and Amyloid Accumulation: Approximately 50% of participants with LLMDs showed tau accumulation in their brains, compared to only 15% of healthy controls. Nearly 29% of LLMD participants had detectable amyloid deposits, versus just 2% of controls.
-
Autopsy Support: The autopsy findings revealed a significantly higher prevalence of tau-related pathologies in individuals who had experienced late-life mania or depression, reinforcing the imaging results.
-
Early Warning Signs: Most participants with LLMDs had no or only mild cognitive decline, indicating that neurodegenerative diseases can initially present as psychiatric symptoms, years before memory loss or other cognitive symptoms become apparent.
-
Frontal Brain Regions: Many participants showed tau accumulation in the frontal regions of the brain, which are critical for emotional regulation and cognitive function.
-
Timeframe: Mood symptoms preceded cognitive or motor symptoms by an average of 7.3 years, as revealed by the autopsy cases.
Expert Commentary
Dr. Shin Kurose from QST highlighted the significance of the findings: “Because most of the participants with LLMDs in our study had no or mild cognitive decline, these results support the evidence that neurodegenerative diseases, including Alzheimer’s and non-Alzheimer’s tau-related pathologies, can initially manifest as psychiatric symptoms.”
The research team emphasized that timely identification of late-life depression and bipolar disorder could allow for earlier intervention with disease-modifying treatments, potentially improving outcomes for affected individuals.
Conclusion
The study underscores the importance of considering neurodegenerative disease risk in the diagnosis and management of late-life mood disorders. As research continues, these findings may lead to earlier detection and more effective interventions for dementia and related conditions.
Disclaimer:
This news article is based on recent research findings and is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. The views and opinions expressed in this article are those of the researchers and do not necessarily reflect the official policy or position of any healthcare institution.
